Introduction Česky
 
Login |
 
registration
   
have you forgotten your password?
 
send
 

Athero Review

What do we know and what can we really do for families with familial hypercholesterolemia: case report

What do we know and what can we really do for families with familial hypercholesterolemia: case report

Familial hypercholesterolemia is a disorder which does not “hurt”. The brief case report presents the story of a patient in which neither he or his family were compliant...

Authors: Katarína Rašlová, Miloslava Hučková
Issue: 3/2017

Read article

Opinion of the Committee of the Czech Society for Atherosclerosis on the ESC/ EAS Recommendations for Dyslipidemia Diagnostics and Treatment 2016

Opinion of the Committee of the Czech Society for Atherosclerosis on the ESC/ EAS Recommendations for Dyslipidemia Diagnostics and Treatment 2016

The Committee of the Czech Society for Atherosclerosis (CSAT) has drawn up an opinion on the ESC/EAS new recommendations for the management of dyslipidemias published in 2016...

Authors: Michal Vrablík, Jan Piťha, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, Pavel Kraml, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Zuzana Urbanová, Helena Vaverková
Issue: 3/2017

Read article

Secondary dyslipidemia

Secondary dyslipidemia

Secondary dyslipidemia (DLP) arises as a result of other diseases or various exogenous influences. However, genetic predisposition, as it is known in the case of primary DLP...

Authors: Martin Šatný, Michal Vrablík
Issue: 3/2017

Read article

Intensive treatment of dyslipidemia in regional outpatient cardiology office

Intensive treatment of dyslipidemia in regional outpatient cardiology office

We presented briefly initial experiences of outpatient cardiologist in the first ever MedPed center in the Orava region. Reduction of low-density lipoprotein cholesterol (LDL...

Issue: 3/2017

Read article

The role of functional food and nutraceuticals in therapy of hypercholesterolemia

The role of functional food and nutraceuticals in therapy of hypercholesterolemia

Dyslipidemia, arterial hypertension, smoking and type 2 diabetes mellitus are the most important risk factors for cardiovascular diseases (CVD). The first step in treatment of...

Issue: 3/2017

Read article

Myths on diet and prevention of atherosclerosis

Myths on diet and prevention of atherosclerosis

Cardiovascular disease is globally the number one cause of premature death and disability. Physical activities and good nutrition play a crucial role in maintaining health and...

Issue: 2/2017

Read article

What is the role of nutriceuticals in dyslipidemia management? Armolipid Plus

What is the role of nutriceuticals in dyslipidemia management? Armolipid Plus

Low density lipoprotein-cholesterol (LDL-C) reduction is the basic approach in the treatment and prevention of cardiovascular disease on the atherosclerosis background. Except...

Issue: 2/2017

Read article

The study ODYSSEY CHOICE I with alirocumab: more data on PCSK9 inhibition

The study ODYSSEY CHOICE I with alirocumab: more data on PCSK9 inhibition

The search for an optimum method of inhibiting proprotein convertase subtilisin kexin (PCSK9) goes on and the clinical researches into monoclonal antibodies to PCSK9 (PCSK9...

Authors: Michal Vrablík, Eva Tůmová
Issue: 2/2017

Read article

Effect of statins and ezetimibe on the progression of atherosclerosis

Effect of statins and ezetimibe on the progression of atherosclerosis

Recent years have brought a significant amount of new results in the field of atherosclerosis. It is well recognized that low-density lipoprotein cholesterol (LDL-C) lowering...

Issue: 2/2017

Read article

Results of FOURIER study – beginning of the new era in cardiovascular disease prevention?

Results of FOURIER study – beginning of the new era in cardiovascular disease prevention?

Increased levels of LDL-cholesterol (LDL-C) represent serious risk factor in the pathogenesis of atherosclerosis and its complications. There were no new approaches how to reach...

Issue: 2/2017

Read article